XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Accumulated Deficit
Beginning balance (in shares) at Jun. 30, 2018   44,834     5,806  
Beginning balance at Jun. 30, 2018 $ 310,932 $ 45 $ 678,549 $ (30,633) $ (129,914) $ (207,115)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for employee stock purchase plan and upon exercise of stock options (in shares)   40     (126)  
Issuance of common stock for employee stock purchase plan and upon exercise of stock options 3,856 $ 1 1,036   $ 2,819  
Vesting of restricted stock awards (in shares)   920        
Vesting of restricted stock awards 0          
Stock compensation plan expense 31,978   31,978      
Warrant settlements (in shares)   932        
Warrant settlements (4) $ 1 (5)      
Minimum pension liability adjustments, net of tax (38)     (38)    
Net income 5,875         5,875
Unrealized gain on available for sale securities 11     11    
Change in fair value on interest rate hedging instruments (1,952)     (1,952)    
Foreign currency translation adjustments (2,588)     (2,588)    
Ending balance (in shares) at Mar. 31, 2019   46,726     5,680  
Ending balance at Mar. 31, 2019 374,333 $ 47 711,558 (35,200) $ (127,095) (174,977)
Beginning balance (in shares) at Dec. 31, 2018   46,468     5,730  
Beginning balance at Dec. 31, 2018 360,845 $ 46 700,520 (35,704) $ (128,216) (175,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for employee stock purchase plan and upon exercise of stock options (in shares)   21     (50)  
Issuance of common stock for employee stock purchase plan and upon exercise of stock options 2,118 $ 1 996   $ 1,121  
Vesting of restricted stock awards (in shares)   237        
Vesting of restricted stock awards 0          
Stock compensation plan expense 10,042   10,042      
Minimum pension liability adjustments, net of tax 18     18    
Net income 824         824
Unrealized gain on available for sale securities 5     5    
Change in fair value on interest rate hedging instruments (841)     (841)    
Foreign currency translation adjustments 1,322     1,322    
Ending balance (in shares) at Mar. 31, 2019   46,726     5,680  
Ending balance at Mar. 31, 2019 374,333 $ 47 711,558 (35,200) $ (127,095) (174,977)
Beginning balance (in shares) at Jun. 30, 2019   46,995     5,680  
Beginning balance at Jun. 30, 2019 379,377 $ 47 721,438 (43,593) $ (127,095) (171,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for employee stock purchase plan and upon exercise of stock options (in shares)   13     (123)  
Issuance of common stock for employee stock purchase plan and upon exercise of stock options 4,133   1,226   $ 2,907  
Vesting of restricted stock awards (in shares)   881        
Vesting of restricted stock awards 1 $ 1        
Repurchase of common stock to be held in treasury (in shares)         418  
Repurchase of common stock to be held in treasury (19,145)       $ (19,145)  
Stock compensation plan expense 31,476   31,476      
Minimum pension liability adjustments, net of tax 13     13    
Net income (6,226)         (6,226)
Unrealized gain on available for sale securities 67     67    
Change in fair value on interest rate hedging instruments (3,590)     (3,590)    
Foreign currency translation adjustments (3,248)     (3,248)    
Ending balance (in shares) at Mar. 31, 2020   47,889     5,975  
Ending balance at Mar. 31, 2020 382,895 $ 48 754,140 (50,351) $ (143,333) (177,609)
Beginning balance (in shares) at Dec. 31, 2019   47,645     5,948  
Beginning balance at Dec. 31, 2019 395,934 $ 48 744,359 (37,631) $ (140,701) (170,141)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for employee stock purchase plan and upon exercise of stock options (in shares)         (63)  
Issuance of common stock for employee stock purchase plan and upon exercise of stock options 1,958   450   $ 1,508  
Vesting of restricted stock awards (in shares)   244        
Vesting of restricted stock awards 0 $ 0        
Repurchase of common stock to be held in treasury (in shares)         90  
Repurchase of common stock to be held in treasury (4,140)       $ (4,140)  
Stock compensation plan expense 9,331   9,331      
Minimum pension liability adjustments, net of tax 5     5    
Net income (7,468)         (7,468)
Unrealized gain on available for sale securities 70     70    
Change in fair value on interest rate hedging instruments (3,482)     (3,482)    
Foreign currency translation adjustments (9,313)     (9,313)    
Ending balance (in shares) at Mar. 31, 2020   47,889     5,975  
Ending balance at Mar. 31, 2020 $ 382,895 $ 48 $ 754,140 $ (50,351) $ (143,333) $ (177,609)